Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

12.23
Delayed Data
As of Aug 26
 +0.13 / +1.07%
Today’s Change
6.00
Today|||52-Week Range
13.18
+16.92%
Year-to-Date

Today’s Trading

Previous close12.10
Today’s open12.12
Day’s range12.00 - 12.28
Volume170,265
Average volume (3 months)319,735
Market cap$485.6M
Dividend yield--
Data as of 08/26/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-33.68%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book7.06

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...-0.06-1.30%
OTICOtonomy Inc+0.33+2.10%
ARDXArdelyx Inc+0.29+2.88%
PDLIPDL BioPharma Inc+0.12+4.38%
Data as of 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs